Paradigm Biocapital Advisors LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$2.2T
Holdings
27
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 5,269,433 | $373.7B | 17.12% | |
| 2 | ACLXARCELLX INC | 4,492,032 | $294.7B | 13.50% | |
| 3 | RVMDREVOLUTION MEDICINES INC | 6,178,111 | $218.5B | 10.01% | |
| 4 | ONCBEIGENE LTD | 666,024 | $181.3B | 8.30% | |
| 5 | MRUSMERUS N V | 3,369,699 | $141.8B | 6.50% | |
| 6 | TARSTARSUS PHARMACEUTICALS INC | 2,610,197 | $134.1B | 6.14% | |
| 7 | EWTXEDGEWISE THERAPEUTICS INC | 4,894,556 | $107.7B | 4.93% | Call |
| 8 | JANXJANUX THERAPEUTICS INC | 3,329,909 | $89.9B | 4.12% | |
| 9 | CRNXCRINETICS PHARMACEUTICALS IN | 1,946,168 | $65.3B | 2.99% | |
| 10 | PCVXVAXCYTE INC | 1,696,481 | $64.1B | 2.93% | |
| 11 | IRONDISC MEDICINE INC | 1,210,971 | $60.1B | 2.75% | |
| 12 | COGTCOGENT BIOSCIENCES INC | 8,963,655 | $53.7B | 2.46% | |
| 13 | LENZLENZ THERAPEUTICS INC | 1,511,932 | $38.9B | 1.78% | |
| 14 | APGEAPOGEE THERAPEUTICS INC | 961,707 | $35.9B | 1.65% | |
| 15 | ARGXARGENX SE | 59,679 | $35.3B | 1.62% | |
| 16 | CYTKCYTOKINETICS INC | 858,664 | $34.5B | 1.58% | |
| 17 | IM8NINSMED INC | 451,359 | $34.4B | 1.58% | |
| 18 | SYRESPYRE THERAPEUTICS INC | 2,127,205 | $34.3B | 1.57% | |
| 19 | MTSRMETSERA INC | 1,191,462 | $32.4B | 1.49% | |
| 20 | VRDNVIRIDIAN THERAPEUTICS INC | 2,095,079 | $28.2B | 1.29% | |
| 21 | OLMAOLEMA PHARMACEUTICALS INC | 6,741,172 | $25.3B | 1.16% | |
| 22 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 627,423 | $24.5B | 1.12% | |
| 23 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,465,334 | $22.9B | 1.05% | |
| 24 | YMABUSDY-MABS THERAPEUTICS INC | 4,236,346 | $18.8B | 0.86% | |
| 25 | ERASERASCA INC | 10,802,354 | $14.8B | 0.68% | |
| 26 | OCULOCULAR THERAPEUTIX INC | 1,314,018 | $9.6B | 0.44% | |
| 27 | IMTXIMMATICS N.V | 1,907,108 | $8.6B | 0.39% |